From: A phase I study of nedaplatin, pemetrexed and thoracic intensity-modulated radiotherapy for inoperable stage III lung adenocarcinoma
Dose level
N
Radiation therapy dose (Gy)
Dose delay due to AE
Level 1
3
62
62a
64
1 (3Â days)
Level 2
6
60
0
Level 3
1 (7Â days)
60b